  {"id":40295,"date":"2017-07-11T14:35:58","date_gmt":"2017-07-11T05:35:58","guid":{"rendered":"http:\/\/www.veeva.com\/jp\/?p=40295"},"modified":"2018-08-10T15:46:36","modified_gmt":"2018-08-10T06:46:36","slug":"veeva-further-expands-clinical-leadership","status":"publish","type":"post","link":"https:\/\/www.veeva.com\/jp\/news\/veeva-further-expands-clinical-leadership\/","title":{"rendered":"³Ô¹Ï±¬ÁÏ\u3001\u30af\u30ea\u30cb\u30ab\u30eb\u30ea\u30fc\u30c0\u30fc\u30b7\u30c3\u30d7\u3092\u3055\u3089\u306b\u5f37\u5316"},"content":{"rendered":"<p style=\"text-align: right;\">2017\u5e747\u670811\u65e5<\/p>\n<p style=\"text-align: right;\">³Ô¹Ï±¬ÁÏ Japan\u682a\u5f0f\u4f1a\u793e<\/p>\n<p>&nbsp;<\/p>\n<p>³Ô¹Ï±¬ÁÏ Systems\u3010NYSE:VEEV\u3011(\u672c\u793e : \u30ab\u30ea\u30d5\u30a9\u30eb\u30cb\u30a2\u5dde\u30d7\u30ec\u30b6\u30f3\u30c8\u30f3\u3001\u65e5\u672c\u6cd5\u4eba \u672c\u793e : \u6771\u4eac\u90fd\u6e0b\u8c37\u533a\u3001\u65e5\u672c\u6cd5\u4eba\u4ee3\u8868\u53d6\u7de0\u5f79 : \u5ca1\u6751 \u5d07\u3001\u4ee5\u4e0b ³Ô¹Ï±¬ÁÏ)\u306f\u3001<a href=\"https:\/\/www.veeva.com\/jp\/products\/clinical-operations\/leadership\/\"><strong>\u81e8\u5e8a\u8a66\u9a13\u30aa\u30da\u30ec\u30fc\u30b7\u30e7\u30f3\u90e8\u9580<\/strong><\/a>\u3068<a href=\"https:\/\/www.veeva.com\/jp\/products\/clinical-data-management\/leadership\/\"><strong>\u81e8\u5e8a\u30c7\u30fc\u30bf\u30de\u30cd\u30b8\u30e1\u30f3\u30c8\u90e8\u9580<\/strong><\/a>\u306b\u30a8\u30ad\u30b9\u30d1\u30fc\u30c85\u540d\u3092\u52a0\u3048\u308b\u3053\u3068\u3067\u3001\u4eca\u5f8c\u3082\u30af\u30ea\u30cb\u30ab\u30eb\u5206\u91ce\u3067\u306e\u30ea\u30fc\u30c0\u30fc\u30b7\u30c3\u30d7\u3092\u5f37\u5316\u3059\u308b\u3068\u767a\u8868\u3057\u307e\u3057\u305f\u3002 (\u672c\u30ea\u30ea\u30fc\u30b9\u306f\u3001³Ô¹Ï±¬ÁÏ\u7c73\u56fd\u672c\u793e\u304c\u767a\u8868\u3057\u305f\u5831\u9053\u8cc7\u6599\u306e\u6284\u8a33\u3067\u3059)<\/p>\n<p>³Ô¹Ï±¬ÁÏ Systems\u306e\u5275\u7acb\u8005\u517cCEO\u3067\u3042\u308bPeter Gassner\u306f\u3001\u6b21\u306e\u3088\u3046\u306b\u8ff0\u3079\u3066\u3044\u307e\u3059\u3002\u300c³Ô¹Ï±¬ÁÏ\u306f\u3001\u7d71\u5408\u5316\u3055\u308c\u305f\u30af\u30e9\u30a6\u30c9\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u4e0a\u3067\u6700\u9ad8\u306e\u81e8\u5e8a\u8a66\u9a13\u696d\u52d9\u95a2\u9023\u306e\u88fd\u54c1\u3092\u5e02\u5834\u5c55\u958b\u3059\u308b\u3053\u3068\u306b\u6ce8\u529b\u3057\u3066\u3044\u307e\u3059\u3002\u5f53\u793e\u306e\u30df\u30c3\u30b7\u30e7\u30f3\u306f\u3001\u5c02\u9580\u5206\u91ce\u306b\u95a2\u3059\u308b\u6df1\u3044\u77e5\u8b58\u3068\u30a4\u30ce\u30d9\u30fc\u30b7\u30e7\u30f3\u306e\u4e00\u8cab\u3057\u305f\u5b9f\u7e3e\u3092\u6301\u3061\u3001\u696d\u754c\u304b\u3089\u3082\u5e83\u304f\u8a55\u4fa1\u3055\u308c\u3066\u3044\u308b\u4eba\u6750\u3092\u96c6\u3081\u308b\u3053\u3068\u3067\u3059\u3002\u300d<\/p>\n<p><strong>³Ô¹Ï±¬ÁÏ\u306e\u30af\u30ea\u30cb\u30ab\u30eb\u30c1\u30fc\u30e0\u306b\u52a0\u308f\u3063\u305f\u65b0\u30e1\u30f3\u30d0\u30fc\uff1a<\/strong><br \/>\n<strong><a href=\"https:\/\/www.veeva.com\/jp\/products\/clinical-data-management\/leadership\/#raymond-letulle\">Raymond Letulle\uff08³Ô¹Ï±¬ÁÏ Vault EDC\u62c5\u5f53\u30b7\u30cb\u30a2\u30f4\u30a1\u30a4\u30b9\u30d7\u30ec\u30b8\u30c7\u30f3\u30c8\uff09<\/a>\u00a0<\/strong>\u2013 \u30a8\u30f3\u30bf\u30fc\u30d7\u30e9\u30a4\u30ba\u30bd\u30d5\u30c8\u30a6\u30a7\u30a2\u306e\u5206\u91ce\u306725\u5e74\u4ee5\u4e0a\u306e\u7d4c\u9a13\u3092\u6709\u3059\u308bRaymond\u306f\u3001Medrio\u793e\u3067\u30c1\u30fc\u30d5\u30aa\u30da\u30ec\u30fc\u30c6\u30a3\u30f3\u30b0\u30aa\u30d5\u30a3\u30b5\u30fc\u304a\u3088\u3073\u30d8\u30c3\u30c9\u30aa\u30d6\u30d7\u30ed\u30c0\u30af\u30c8\u3068\u3057\u3066\u88fd\u54c1\u6226\u7565\u3092\u62c5\u5f53\u3057\u3001EDC\u3084eSource\u306a\u3069\u306eeClinical\u30bd\u30ea\u30e5\u30fc\u30b7\u30e7\u30f3\u306e\u8a2d\u8a08\u30c1\u30fc\u30e0\u306e\u904b\u55b6\u3084\u88fd\u54c1\u7ba1\u7406\u3092\u884c\u3044\u307e\u3057\u305f\u3002³Ô¹Ï±¬ÁÏ\u3067\u306f<a href=\"https:\/\/www.veeva.com\/jp\/products\/vault-edc\/\"><strong>Vault EDC<\/strong><\/a>\u3068<strong>Vault eSource<\/strong>\u306e\u958b\u767a\u6307\u63ee\u3092\u62c5\u5f53\u3057\u3001\u6280\u8853\u9769\u65b0\u306b\u3088\u3063\u3066\u81e8\u5e8a\u8a66\u9a13\u696d\u52d9\u306e\u8fc5\u901f\u5316\u3001\u30c7\u30fc\u30bf\u54c1\u8cea\u306e\u5411\u4e0a\u3001\u305d\u3057\u3066\u30b3\u30b9\u30c8\u524a\u6e1b\u3068\u7c21\u7d20\u5316\u3092\u76ee\u6307\u3057\u307e\u3059\u3002<\/p>\n<p><a href=\"https:\/\/www.veeva.com\/jp\/products\/clinical-data-management\/leadership\/#ami-dudzinski-mehr\"><strong>Ami Dudzinski Mehr\uff08³Ô¹Ï±¬ÁÏ Vault EDC\u30b5\u30fc\u30d3\u30b9\u62c5\u5f53\u30f4\u30a1\u30a4\u30b9\u30d7\u30ec\u30b8\u30c7\u30f3\u30c8\uff09<\/strong><\/a> \u2013 Ami\u306f\u30e9\u30a4\u30d5\u30b5\u30a4\u30a8\u30f3\u30b9\u5206\u91ce\u306b\u304a\u3051\u308b\u7814\u7a76\u958b\u767a\u304a\u3088\u3073\u30b3\u30f3\u30b5\u30eb\u30c6\u30a3\u30f3\u30b0\u306a\u3069\u306e\u5c02\u9580\u7684\u306a\u30b5\u30fc\u30d3\u30b9\u5206\u91ce\u3067\u3001\u304a\u3088\u305d20\u5e74\u306b\u308f\u305f\u308b\u7d4c\u9a13\u3092\u6709\u3057\u3066\u3044\u307e\u3059\u3002\u307e\u305f\u30d5\u30a7\u30fc\u30baI\u304b\u3089IV\u306e\u81e8\u5e8a\u8a66\u9a13\u696d\u52d9\u7528SaaS\u578bEDC\u304a\u3088\u3073IRT\/IVRS\u3092\u5b9f\u65bd\u3059\u308b\u30bd\u30d5\u30c8\u30a6\u30a7\u30a2\u30fb\u30c7\u30ea\u30d0\u30ea\u30fc\u65b9\u6cd5\u306b\u95a2\u3059\u308b\u5e45\u5e83\u3044\u77e5\u8b58\u3092\u6709\u3057\u3066\u3044\u307e\u3059\u3002\u76f4\u8fd1\u3067\u306f\u3001Oracle\u793e\u3067EDC\u306e\u30b5\u30fc\u30d3\u30b9\u30c1\u30fc\u30e0\u3092\u7d71\u62ec\u3057\u3066\u3044\u307e\u3057\u305f\u3002³Ô¹Ï±¬ÁÏ\u3067\u306f\u3001³Ô¹Ï±¬ÁÏ Vault EDC\u30b0\u30ed\u30fc\u30d0\u30eb\u30b5\u30fc\u30d3\u30b9\u30c1\u30fc\u30e0\u306e\u8cac\u4efb\u8005\u3068\u3057\u3066\u3001\u30c7\u30ea\u30d0\u30ea\u30fc\u30a8\u30af\u30bb\u30ec\u30f3\u30b9\u3001\u54c1\u8cea\u3001\u30b9\u30d4\u30fc\u30c9\u3092\u5b9f\u73fe\u3057\u307e\u3059\u3002<\/p>\n<p><strong><a href=\"https:\/\/www.veeva.com\/jp\/products\/clinical-data-management\/leadership\/#hugo-cervantez\">Hugo Cervantes\uff08³Ô¹Ï±¬ÁÏ Vault EDC\u62c5\u5f53\u30f4\u30a1\u30a4\u30b9\u30d7\u30ec\u30b8\u30c7\u30f3\u30c8\uff09<\/a>\u00a0<\/strong>\u2013 Vault EDC\u306e\u6226\u7565\u3001\u5e02\u5834\u5c0e\u5165\u3001\u9867\u5ba2\u30a8\u30f3\u30b2\u30fc\u30b8\u30e1\u30f3\u30c8\u306e\u8cac\u4efb\u8005\u3092\u52d9\u3081\u308bHugo\u306f\u3001\u3053\u308c\u307e\u306715\u5e74\u9593\u306b\u308f\u305f\u3063\u3066\u3001\u7d4c\u55b6\u30b3\u30f3\u30b5\u30eb\u30c6\u30a3\u30f3\u30b0\u306a\u3069\u306e\u5c02\u9580\u7684\u306a\u30b5\u30fc\u30d3\u30b9\u3092\u63d0\u4f9b\u3057\u3001\u30d0\u30a4\u30aa\u533b\u85ac\u54c1\u306e\u7814\u7a76\u958b\u767a\u4f01\u696d\u306e\u751f\u7523\u6027\u5411\u4e0a\u3001\u30a4\u30ce\u30d9\u30fc\u30b7\u30e7\u30f3\u3001\u6210\u9577\u3092\u652f\u63f4\u3057\u3066\u304d\u307e\u3057\u305f\u3002³Ô¹Ï±¬ÁÏ\u5165\u793e\u524d\u306f\u3001Phase Forward\u793e\uff08\u73feOracle\uff09\u306e\u30d0\u30a4\u30aa\u533b\u85ac\u54c1\u4f01\u696d\u5411\u3051EDC\u3092\u62c5\u5f53\u5f8c\u3001QuintilesIMS\u793e\u3067\u7d4c\u55b6\u6226\u7565\u62c5\u5f53\u30b7\u30cb\u30a2\u30c7\u30a3\u30ec\u30af\u30bf\u30fc\u3092\u62c5\u5f53\u3057\u3001Deloitte\u793e\u3068Accenture\u793e\u3067\u3082\u5e79\u90e8\u8077\u3092\u6b74\u4efb\u3057\u307e\u3057\u305f\u3002<\/p>\n<p><a href=\"https:\/\/www.veeva.com\/jp\/products\/clinical-data-management\/leadership\/#jason-rizzo\"><strong>Jason Rizzo\uff08³Ô¹Ï±¬ÁÏ Vault EDC\u30bb\u30fc\u30eb\u30b9\u62c5\u5f53\u30b7\u30cb\u30a2\u30c7\u30a3\u30ec\u30af\u30bf\u30fc\uff09<\/strong><\/a> \u2013 Jason\u306f\u304a\u3088\u305d20\u5e74\u306b\u308f\u305f\u308b\u30e9\u30a4\u30d5\u30b5\u30a4\u30a8\u30f3\u30b9\u696d\u754c\u3067\u306e\u7d4c\u9a13\u3092\u6d3b\u304b\u3057\u3001³Ô¹Ï±¬ÁÏ\u306eEDC\u30bb\u30fc\u30eb\u30b9\u30c1\u30fc\u30e0\u3092\u7387\u3044\u3066\u3044\u307e\u3059\u3002\u9867\u5ba2\u3092\u4e2d\u5fc3\u306b\u8003\u3048\u63a2\u6c42\u5fc3\u306b\u3042\u3075\u308c\u308b\u30bb\u30fc\u30eb\u30b9\u30c1\u30fc\u30e0\u3092\u69cb\u7bc9\u3057\u3066\u304d\u305fJason\u306f\u3001eClinical\u30a2\u30d7\u30ea\u30b1\u30fc\u30b7\u30e7\u30f3\u306e\u5e45\u5e83\u3044\u5c02\u9580\u77e5\u8b58\u3068\u3001\u533b\u85ac\u54c1\u958b\u767a\u306b\u304a\u3051\u308b\u81e8\u5e8a\u30c7\u30fc\u30bf\u30de\u30cd\u30b8\u30e1\u30f3\u30c8\u3084\u81e8\u5e8a\u8a66\u9a13\u696d\u52d9\u306b\u95a2\u3059\u308b\u6df1\u3044\u5c02\u9580\u77e5\u8b58\u306e\u4e21\u65b9\u3092\u517c\u306d\u5099\u3048\u3066\u3044\u307e\u3059\u3002 ³Ô¹Ï±¬ÁÏ\u5165\u793e\u524d\u306f\u3001Medidata Solutions\u793e\u306e\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u30bb\u30fc\u30eb\u30b9\u62c5\u5f53\u30f4\u30a1\u30a4\u30b9\u30d7\u30ec\u30b8\u30c7\u30f3\u30c8\u306a\u3069\u3001\u69d8\u3005\u306a\u5f79\u8077\u3092\u7d4c\u9a13\u3057\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>Henry Galio\uff08³Ô¹Ï±¬ÁÏ Vault CTMS\u62c5\u5f53\u30b7\u30cb\u30a2\u30c7\u30a3\u30ec\u30af\u30bf\u30fc\uff09 \u2013 Henry\u306fVault CTMS\u306e\u6226\u7565\u958b\u767a\u306b\u5f93\u4e8b\u3057\u3066\u3044\u307e\u3059\u3002\u696d\u52d9\u30bd\u30d5\u30c8\u30a6\u30a7\u30a2\u696d\u754c\u3067\u306e\u304a\u3088\u305d25\u5e74\u306b\u308f\u305f\u308b\u7d4c\u9a13\u3068\u3001\u30af\u30ea\u30cb\u30ab\u30eb\u5206\u91ce\u3067\u306e20\u5e74\u306e\u7d4c\u9a13\u3092\u6709\u3059\u308bHenry\u306f\u300150\u4ef6\u4ee5\u4e0a\u306eCTMS\u30d7\u30ed\u30b8\u30a7\u30af\u30c8\u3092\u5b9f\u65bd\u3057\u3001\u7d04200\u793e\u306e\u30e9\u30a4\u30d5\u30b5\u30a4\u30a8\u30f3\u30b9\u4f01\u696d\u306bCTMS\u306b\u95a2\u3059\u308b\u30a2\u30c9\u30d0\u30a4\u30b9\u3092\u884c\u3063\u3066\u3044\u307e\u3059\u3002³Ô¹Ï±¬ÁÏ\u5165\u793e\u524d\u306f\u3001Oracle\u793e\u306e\u30af\u30ea\u30cb\u30ab\u30eb\u62c5\u5f53\u30b7\u30cb\u30a2\u30c7\u30a3\u30ec\u30af\u30bf\u30fc\u3068\u3057\u3066\u3001CTMS\u304a\u3088\u3073CDA\u7528\u30af\u30e9\u30a6\u30c9\u30b5\u30fc\u30d3\u30b9\u3092\u4f5c\u6210\u3059\u308b\u30bd\u30ea\u30e5\u30fc\u30b7\u30e7\u30f3\u30a2\u30fc\u30ad\u30c6\u30af\u30c8\u30c1\u30fc\u30e0\u3092\u7d71\u62ec\u3057\u3066\u3044\u307e\u3057\u305f\u3002<\/p>\n<p>³Ô¹Ï±¬ÁÏ\u30af\u30ea\u30cb\u30ab\u30eb\u30c1\u30fc\u30e0\u306eLinkedIn\u30a2\u30ab\u30a6\u30f3\u30c8\uff1a<br \/>\n<a href=\"https:\/\/www.linkedin.com\/in\/raymond-letulle-6461\/\"><strong>Ray Letulle<\/strong><\/a><br \/>\n<a href=\"https:\/\/www.linkedin.com\/in\/amimehr\/\"><strong>Ami Dudzinski Mehr<\/strong><\/a><br \/>\n<a href=\"https:\/\/www.linkedin.com\/in\/jasonrizzo1\/\"><strong>Jason Rizzo<\/strong><\/a><br \/>\n<a href=\"https:\/\/www.linkedin.com\/in\/hugo-cervantes-b346543\/\"><strong>Hugo Cervantes<\/strong><\/a><br \/>\n<a href=\"https:\/\/www.linkedin.com\/in\/hgalio\/\"><strong>Henry Galio<\/strong><\/a><\/p>\n<p>&nbsp;<\/p>\n<p><strong>\u3010³Ô¹Ï±¬ÁÏ Systems\u793e\u306b\u3064\u3044\u3066\u3011<br \/>\n<\/strong>³Ô¹Ï±¬ÁÏ Systems\u793e\u306f\u30b0\u30ed\u30fc\u30d0\u30eb\u306a\u30e9\u30a4\u30d5\u30b5\u30a4\u30a8\u30f3\u30b9\u4f01\u696d\u5411\u3051\u306b\u30af\u30e9\u30a6\u30c9\u30d9\u30fc\u30b9\u306e\u30bd\u30d5\u30c8\u30a6\u30a7\u30a2\u3092\u63d0\u4f9b\u3059\u308b\u30ea\u30fc\u30c7\u30a3\u30f3\u30b0\u30ab\u30f3\u30d1\u30cb\u30fc\u3067\u3059\u3002\u4e16\u754c\u6700\u5927\u898f\u6a21\u306e\u88fd\u85ac\u4f1a\u793e\u304b\u3089\u30d0\u30a4\u30aa\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u5206\u91ce\u306e\u65b0\u8208\u4f01\u696d\u307e\u3067500\u793e\u3092\u8d85\u3048\u308b\u9867\u5ba2\u3092\u64c1\u3057\u3001\u6280\u8853\u9769\u65b0\u3078\u306e\u53d6\u308a\u7d44\u307f\u3084\u5353\u8d8a\u3057\u305f\u88fd\u54c1\u529b\u306b\u3088\u3063\u3066\u3001\u304a\u5ba2\u69d8\u306e\u6210\u529f\u3092\u30b5\u30dd\u30fc\u30c8\u3057\u3066\u3044\u307e\u3059\u3002³Ô¹Ï±¬ÁÏ\u306f\u3001\u30b5\u30f3\u30d5\u30e9\u30f3\u30b7\u30b9\u30b3\u306e\u30d9\u30a4\u30a8\u30ea\u30a2\u306b\u672c\u793e\u3092\u7f6e\u304d\u3001\u30e8\u30fc\u30ed\u30c3\u30d1\u3001\u30a2\u30b8\u30a2\u3001\u30e9\u30c6\u30f3\u30a2\u30e1\u30ea\u30ab\u306b\u62e0\u70b9\u3092\u5c55\u958b\u3057\u3066\u3044\u307e\u3059\u3002\u8a73\u3057\u304f\u306f\u3001<span style=\"color: #ff991c;\"><a style=\"text-decoration: none; font-weight: bold; color: #ff991c;\" href=\"https:\/\/veeva.com\/jp\/\" target=\"_blank\" rel=\"noopener noreferrer\">\u516c\u5f0f\u30b5\u30a4\u30c8<\/a><\/span>\u3092\u3054\u89a7\u304f\u3060\u3055\u3044\u3002<\/p>\n<p><strong>\u3010Forward-looking Statements\u3011<\/strong><\/p>\n<p>This release contains forward-looking statements, including the market demand for and acceptance of ³Ô¹Ï±¬ÁÏ\u2019s products and services, the results from use of ³Ô¹Ï±¬ÁÏ\u2019s products and services, and general business conditions, particularly in the life sciences industry. Any forward-looking statements contained in this press release are based upon ³Ô¹Ï±¬ÁÏ\u2019s historical performance and its current plans, estimates, and expectations, and are not a representation that such plans, estimates, or expectations will be achieved. These forward-looking statements represent ³Ô¹Ï±¬ÁÏ\u2019s expectations as of the date of this press announcement. Subsequent events may cause these expectations to change, and ³Ô¹Ï±¬ÁÏ disclaims any obligation to update the forward-looking statements in the future. These forward-looking statements are subject to known and unknown risks and uncertainties that may cause actual results to differ materially. Additional risks and uncertainties that could affect ³Ô¹Ï±¬ÁÏ\u2019s financial results are included under the captions, \u201cRisk Factors\u201d and \u201cManagement\u2019s Discussion and Analysis of Financial Condition and Results of Operations,\u201d in the company\u2019s filing on Form 10-Q for the period ended April 30, 2017. This is available on the company\u2019s website at <a href=\"https:\/\/www.veeva.com\/\">www.veeva.com<\/a> under the Investors section and on the SEC\u2019s website at <a href=\"http:\/\/www.sec.gov\/\">www.sec.gov<\/a>. Further information on potential risks that could affect actual results will be included in other filings ³Ô¹Ï±¬ÁÏ makes with the SEC from time to time.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>2017\u5e747\u670811\u65e5 ³Ô¹Ï±¬ÁÏ Japan\u682a\u5f0f\u4f1a\u793e &nbsp; ³Ô¹Ï±¬ÁÏ Systems\u3010NYSE:VEEV\u3011(\u672c\u793e : \u30ab\u30ea\u30d5\u30a9\u30eb\u30cb\u30a2\u5dde\u30d7\u30ec\u30b6\u30f3\u30c8\u30f3\u3001\u65e5\u672c\u6cd5\u4eba \u672c\u793e : \u6771\u4eac\u90fd\u6e0b\u8c37\u533a\u3001\u65e5\u672c\u6cd5\u4eba\u4ee3\u8868\u53d6\u7de0\u5f79 : \u5ca1\u6751&hellip;<\/p>\n","protected":false},"author":131,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[322],"tags":[],"class_list":["post-40295","post","type-post","status-publish","format-standard","hentry","category-press-release"],"acf":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/posts\/40295"}],"collection":[{"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/users\/131"}],"replies":[{"embeddable":true,"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/comments?post=40295"}],"version-history":[{"count":4,"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/posts\/40295\/revisions"}],"predecessor-version":[{"id":41748,"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/posts\/40295\/revisions\/41748"}],"wp:attachment":[{"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/media?parent=40295"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/categories?post=40295"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/tags?post=40295"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}